Lates News

U.S. stock market concept stocks of weight-loss drugs accelerated their decline in pre-market trading, with Lilly, Novo and Novo Nordisk falling by more than 5%. White House officials said they expect diabetes and weight-loss drugs to become a focus of attention for lowering drug prices.